AAAAAA
Results:
1-14
|
Results: 14
Authors:
OGILVIE RI
ZBOROWSKASLUIS D
Citation: Ri. Ogilvie et D. Zborowskasluis, CAPTOPRIL AND ANGIOTENSIN-II RECEPTOR ANTAGONIST THERAPY IN A PACING MODEL OF HEART-FAILURE, Canadian journal of cardiology, 14(8), 1998, pp. 1025-1033
Authors:
OGILVIE RI
ELLIS E
LANGLOIS S
MACKENZIE R
SPENCE JD
Citation: Ri. Ogilvie et al., RECOMMENDATIONS FOR SICK-LEAVE FROM WORK FOR PATIENTS WITH HYPERTENSION, Canadian journal of cardiology, 12(1), 1996, pp. 31-32
Authors:
OGILVIE RI
ZBOROWSKASLUIS D
Citation: Ri. Ogilvie et D. Zborowskasluis, EFFECT OF PERINDOPRIL IN PACING-INDUCED CANINE MODELS OF ACUTE AND CHRONIC HEART-FAILURE, Canadian journal of cardiology, 11(10), 1995, pp. 934-940
Authors:
NEKOOEIAN AA
OGILVIE RI
ZBOROWSKASLUIS D
Citation: Aa. Nekooeian et al., ACUTE HEMODYNAMIC-EFFECTS OF DRUGS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM IN ACUTE HEART-FAILURE, Canadian journal of cardiology, 11(1), 1995, pp. 59-64
Authors:
OGILVIE RI
ZBOROWSKASLUIS D
Citation: Ri. Ogilvie et D. Zborowskasluis, ACUTE EFFECT OF L-ARGININE ON HEMODYNAMICS AND VASCULAR CAPACITANCE IN THE CANINE PACING MODEL OF HEART-FAILURE, Journal of cardiovascular pharmacology, 26(3), 1995, pp. 407-413
Authors:
OGILVIE RI
ZBOROWSKASLUIS D
Citation: Ri. Ogilvie et D. Zborowskasluis, VASCULAR CAPACITANCE AND CARDIAC-OUTPUT IN PACING-INDUCED CANINE MODELS OF ACUTE AND CHRONIC HEART-FAILURE, Canadian journal of physiology and pharmacology, 73(11), 1995, pp. 1641-1650
Authors:
OGILVIE RI
Citation: Ri. Ogilvie, THE ARCHITECTURE OF HYPERTENSION, Canadian journal of cardiology, 10, 1994, pp. 2-2
Authors:
OGILVIE RI
ZBOROWSKASLUIS D
Citation: Ri. Ogilvie et D. Zborowskasluis, EFFECT OF CAPTOPRIL TREATMENT ON TOTAL AND CENTRAL VASCULAR CAPACITANCE IN DOGS WITH CHRONIC HEART-FAILURE, Journal of cardiovascular pharmacology, 24(3), 1994, pp. 358-364
Authors:
OGILVIE RI
Citation: Ri. Ogilvie, THE CANADIAN-HYPERTENSION-SOCIETY, Clinical and investigative medicine, 17(1), 1994, pp. 66-67
Authors:
SHAWSTIFFEL TA
WALKER SE
OGILVIE RI
LEENEN FH
Citation: Ta. Shawstiffel et al., PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS DURING MULTIPLE-DOSEADMINISTRATION OF NISOLDIPINE AND PROPRANOLOL, Clinical pharmacology and therapeutics, 55(6), 1994, pp. 661-669
Authors:
LEGAULT L
OGILVIE RI
CARDELLA CJ
LEENEN FHH
Citation: L. Legault et al., CALCIUM-ANTAGONISTS IN HEART-TRANSPLANT RECIPIENTS - EFFECTS ON CARDIAC AND RENAL-FUNCTION AND CYCLOSPORINE PHARMACOKINETICS, Canadian journal of cardiology, 9(5), 1993, pp. 398-404
Authors:
OGILVIE RI
BURGESS ED
CUSSON JR
FELDMAN RD
LEITER LA
MYERS MG
Citation: Ri. Ogilvie et al., REPORT OF THE CANADIAN-HYPERTENSION-SOCIETY CONSENSUS CONFERENCE - PHARMACOLOGICAL TREATMENT OF ESSENTIAL-HYPERTENSION, CMAJ. Canadian Medical Association journal, 149(5), 1993, pp. 575-584
Authors:
OGILVIE RI
ZBOROWSKASLUIS D
Citation: Ri. Ogilvie et D. Zborowskasluis, CAPTOPRIL ATTENUATES PACING-INDUCED ACUTE HEART-FAILURE BY INCREASINGTOTAL VASCULAR CAPACITANCE, Journal of cardiovascular pharmacology, 22(1), 1993, pp. 153-159
Authors:
BURNS RJ
WRIGHT LM
LUMSDEN CH
ZIELINSKI A
OGILVIE RI
Citation: Rj. Burns et al., HIBERNATING MYOCARDIUM - DETECTION BY REST TL-201 INFUSION SPECT, Circulation, 88(4), 1993, pp. 534-534
Risultati:
1-14
|